GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
Lille , Cambridge , Zurich , May 29, 2024 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed...